Fibrin targeting of tissue plasminogen activator-loaded echogenic liposomes

Journal of Drug Targeting

Volumn 15, Issue 2, 2007, Pages 109-114

  Tiukinhoy Laing, Susan D ^a   Buchanan, Kyle ^b   Parikh, Devang ^b   Huang, Shaoling ^a   Macdonald, Robert C ^b   Mcpherson, David D ^a   Klegerman, Melvin E ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ECHO CONTRAST MEDIUM; ECHOGENIC LIPOSOME; FIBRIN; UNCLASSIFIED DRUG; DRUG CARRIER; FIBRINOGEN; LIPOSOME; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BINDING AFFINITY; BLOOD CLOT LYSIS; CONTROLLED STUDY; DRUG FORMULATION; DRUG PROTEIN BINDING; DRUG TARGETING; ECHOCARDIOGRAPHY; ENCAPSULATION; FIBRINOLYTIC THERAPY; IN VITRO STUDY; LIPOSOMAL DELIVERY; NONHUMAN; PRIORITY JOURNAL; SWINE; THROMBUS; ULTRASOUND; ANIMAL; METABOLISM;

ANIMALS; DRUG CARRIERS; FIBRINOGEN; LIPOSOMES; SWINE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 34249739134     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860601140673     Document Type: Article

References (21)

1. Alexandrov, AV, Molina, CA, Grotta, JC, Garami, Z., Ford, SR, Alvarez-Sabin, J., Montaner, J., Saqqur, M., Demchuk, AM, Moye, LA, Hill, MD and Wojner, AW (2004) Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med, 351:21, pp. 2170-2178.
2. Angles-Cano, E. (1986) A spectrophotometric solid-phase fibin-tissue plasminogen activator activity assay (SOFIA-tPA) for high-fibrin-affinity tissue plasminogen activators. Anal Biochem, 153, pp. 201-210.
3. Bangham, AD, Standish, MM and Watkins, JC (1965) Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol, 13, pp. 238-252.
4. Cohen, MG, Tuero, E., Bluguermann, J., Kevorkian, R., Berrocal, DH, Carlevaro, O., Picabea, E., Hudson, MP, Siegel, RJ, Douthat, L., Greenbaum, AB, Echt, D., Weaver, WD and Grinfeld, LR (2003) Transcutaneous ultrasound-facilitated coronary thrombolysis during acute myocardial infarction. Am J Cardiol, 92, pp. 454-457.
5. Demos, SM, Onyuksel, H., Gilbert, J., Roth, SI, Kane, B., Jungblut, P., Pinto, JV, McPherson, DD and Klegerman, ME (1997) In vitro targeting of antibody-conjugated echogenic liposomes for site-specific ultrasonic image enhancement. J Pharm Sci, 86, pp. 167-171.
6. Demos, SM, Dagar, S., Klegerman, M., Nagaraj, A., McPherson, DD and Onyuksel, H. (1998) In vitro targeting of acoustically reflective immunoliposomes to fibrin under various flow conditions. J Drug Target, 5, pp. 507-518.
7. Demos, SM, Alkan-Onyuksel, H., Kane, BJ, Ramani, K., Nagaraj, A., Greene, R., Klegerman, M. and McPherson, DD (1999) In-vivo targeting of acoustically reflective liposomes for intravascular ultrasonic enhancement. J Am Coll Cardiol, 33:3, pp. 867-875.
8. Eccleston, DS, Horrigan, MC and Ellis, SG (1996) Rationale for local drug delivery. Semin Interv Card, 1:1, pp. 8-16.
9. Gurewich, V. (2000) Fibrinolysis: An unfinished agenda. Blood Coagul Fibrinolysis, 11, pp. 401-408.
10. Hamilton, A., Huang, SL, Warnick, D., Stein, A., Rabbat, M., Madhav, T., Kane, B., Nagaraj, A., Klegerman, M., MacDonald, R. and McPherson, D. (2002) Left ventricular thrombus enhancement following intravenous injection of echogenic immunoliposomes: Studies in a new experimental model. Circulation, 105:23, pp. 2772-2778.
11. Heeremans, JL, Gerritsen, HR, Meusen, SP, Mijnheer, FW, Panday, RS Gangaram, Prevost, R., Kluft, C. and Crommelin, DJ (1995) The preparation of tissue-type plasminogen activator (tPA) containing liposomes: Entrapment efficiency and ultracentrifugation damage. J Drug Target, 3, pp. 301-310.
12. Holland, CK, Vaidya, SS, Coussios, CC and Shaw, GJ (2002) Thrombolytic effects of 120 kHz and 1 MHz ultrasound and tissue plasminogen activator on porcine whole blood clots. J Acoust Soc Am, 112, p. 2370.
13. Huang, SL, Hamilton, AJ, Nagaraj, A., Tiukinhoy, SD, Klegerman, ME, McPherson, DD and Macdonald, RC (2001) Improving ultrasound reflectivity and stability of echogenic liposomal dispersions for use as targeted ultrasound contrast agents. J Pharm Sci, 90:12, pp. 1917-1926.
14. Klegerman, ME, Hamilton, AJ, Tiukinhoy, SD, Khan, AA, Huang, SL, MacDonald, RC and McPherson, DD (2002) Fibrin association characteristics of atheroma-targeted echogenic immunoliposomes. Thromb Vasc Biol, 22:5, p. 214.
15. Nesheim, M., Fredenburgh, JC and Larsen, GR (1990) The dissociation constants and stoichiometries of the interactions of lys-plasminogen and chloromethyl ketone derivatives of tissue plasminogen activator and the variant (FEIX with intact fibrin. J Biol Chem, 265, pp. 21541-21548.
16. Nordt, TK and Bode, C. (2003) Thrombolysis: Newer thrombolytic agents and their role in clinical medicine. Heart, 89, pp. 1358-1362.
17. Tiukinhoy-Laing, SD, Huang, S., Klegerman, M., Holland, C., MacDonald, RC and McPherson, DD (2006) Ultrasound-facilitated thrombolysis using tissue-plasminogen activator-loaded echogenic liposomes. Thromb Res
18. Tiukinhoy, S., Mahowald, M., Shively, V., Nagaraj, A., Kane, B., Klegerman, M., MacDonald, R., McPherson, D. and Matsumura, J. (2000) Development of echogenic, plasmid-incorporated, tissue-targeted cationic liposomes that can be used for directed gene delivery. Investig Radiol, 12, pp. 732-738.
19. Tiukinhoy, S., Khan, A., Huang, S., Klegerman, M., MacDonald, R. and McPherson, D. (2004) Novel echogenic drug-immunoliposomes for drug delivery. Investig Radiol, 39, pp. 104-110.
20. Tsurupa, G. and Medved, L. (2001) Fibrinogen αC domains contain cryptic plasminogen and tPA binding sites. Ann NY Acad Sci, 936, pp. 328-330.
21. Van de Werf, FJ (1999) The ideal fibrinolytic: Can drug design improve clinical results?. Eur Heart J, 20, pp. 1452-1458.